1. Home
  2. SOL vs KYTX Comparison

SOL vs KYTX Comparison

Compare SOL & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOL
  • KYTX
  • Stock Information
  • Founded
  • SOL 2005
  • KYTX 2018
  • Country
  • SOL United States
  • KYTX United States
  • Employees
  • SOL N/A
  • KYTX N/A
  • Industry
  • SOL Semiconductors
  • KYTX
  • Sector
  • SOL Technology
  • KYTX
  • Exchange
  • SOL Nasdaq
  • KYTX NYSE
  • Market Cap
  • SOL 84.6M
  • KYTX 92.1M
  • IPO Year
  • SOL 2008
  • KYTX 2024
  • Fundamental
  • Price
  • SOL $1.72
  • KYTX $2.64
  • Analyst Decision
  • SOL Buy
  • KYTX Strong Buy
  • Analyst Count
  • SOL 3
  • KYTX 5
  • Target Price
  • SOL $3.50
  • KYTX $19.00
  • AVG Volume (30 Days)
  • SOL 148.5K
  • KYTX 382.4K
  • Earning Date
  • SOL 05-14-2025
  • KYTX 05-13-2025
  • Dividend Yield
  • SOL N/A
  • KYTX N/A
  • EPS Growth
  • SOL N/A
  • KYTX N/A
  • EPS
  • SOL N/A
  • KYTX N/A
  • Revenue
  • SOL $85,621,000.00
  • KYTX N/A
  • Revenue This Year
  • SOL N/A
  • KYTX N/A
  • Revenue Next Year
  • SOL $45.37
  • KYTX N/A
  • P/E Ratio
  • SOL N/A
  • KYTX N/A
  • Revenue Growth
  • SOL N/A
  • KYTX N/A
  • 52 Week Low
  • SOL $1.04
  • KYTX $1.78
  • 52 Week High
  • SOL $3.00
  • KYTX $16.64
  • Technical
  • Relative Strength Index (RSI)
  • SOL 60.33
  • KYTX 57.79
  • Support Level
  • SOL $1.63
  • KYTX $2.47
  • Resistance Level
  • SOL $1.87
  • KYTX $2.82
  • Average True Range (ATR)
  • SOL 0.11
  • KYTX 0.23
  • MACD
  • SOL 0.02
  • KYTX 0.04
  • Stochastic Oscillator
  • SOL 67.77
  • KYTX 68.42

About SOL Emeren Group Ltd each representing 10 shares

Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

Share on Social Networks: